BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35182283)

  • 1. PrEP Use, Sexual Behaviour, and PrEP Adherence Among Men who have Sex with Men Living in Wales Prior to and During the COVID-19 Pandemic.
    Gillespie D; Couzens Z; de Bruin M; Hughes DA; Jones A; Ma R; Williams A; Wood F; Blee K; Bradshaw HS; Drayton R; Knapper C; Hood K
    AIDS Behav; 2022 Aug; 26(8):2746-2757. PubMed ID: 35182283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Between- and Within-Individual Sociodemographic and Psychological Determinants of PrEP Adherence Among Men Who have Sex with Men Prescribed a Daily PrEP Regimen in Wales.
    Gillespie D; de Bruin M; Hughes DA; Ma R; Williams A; Wood F; Couzens Z; Jones A; Hood K
    AIDS Behav; 2023 May; 27(5):1564-1572. PubMed ID: 36322216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Sexual Behavior, PrEP Adherence, and Access to Sexual Health Services Because of the COVID-19 Pandemic Among a Cohort of PrEP-Using MSM in the South.
    Pampati S; Emrick K; Siegler AJ; Jones J
    J Acquir Immune Defic Syndr; 2021 May; 87(1):639-643. PubMed ID: 33512848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early impact of COVID-19 social distancing measures on reported sexual behaviour of HIV pre-exposure prophylaxis users in Wales.
    Gillespie D; Knapper C; Hughes D; Couzens Z; Wood F; de Bruin M; Ma R; Jones AT; Williams A; Hood K
    Sex Transm Infect; 2021 Mar; 97(2):85-87. PubMed ID: 32967930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences of men who have sex with men when initiating, implementing and persisting with HIV pre-exposure prophylaxis.
    Gillespie D; Wood F; Williams A; Ma R; de Bruin M; Hughes DA; Jones AT; Couzens Z; Hood K
    Health Expect; 2022 Aug; 25(4):1332-1341. PubMed ID: 35426223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study.
    Winter BL; Hovaguimian F; Kouyos RD; Schmidt AJ; Bernasconi E; Braun DL; Calmy A; Notter J; Stoeckle M; Surial B; Christinet V; Cavassini M; Depmeier C; Läuchli S; Boffi El Amari E; Reinacher M; Rasi M; Bruggmann P; Haerry D; Bize R; Low N; Lehner A; Quednow BB; Fehr JS; Hampel B
    Swiss Med Wkly; 2022 Jun; 152():w30192. PubMed ID: 35758418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alignment of PrEP use and sexual behavior over four months among men who have sex with men in the southern United States.
    Jones J; Pampati S; Siegler AJ
    AIDS Behav; 2022 Oct; 26(10):3378-3385. PubMed ID: 35429308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PrEP Use and Persistence Among Young Sexual Minority Men 17-24 Years Old During the COVID-19 Pandemic.
    Hong C; Horvath KJ; Stephenson R; Nelson KM; Petroll AE; Walsh JL; John SA
    AIDS Behav; 2022 Mar; 26(3):631-638. PubMed ID: 34387777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 restrictions and changing sexual behaviours in HIV-negative MSM at high risk of HIV infection in London, UK.
    Hyndman I; Nugent D; Whitlock GG; McOwan A; Girometti N
    Sex Transm Infect; 2021 Nov; 97(7):521-524. PubMed ID: 33462118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study.
    Grulich AE; Guy R; Amin J; Jin F; Selvey C; Holden J; Schmidt HA; Zablotska I; Price K; Whittaker B; Chant K; Cooper C; McGill S; Telfer B; Yeung B; Levitt G; Ogilvie EE; Dharan NJ; Hammoud MA; Vaccher S; Watchirs-Smith L; McNulty A; Smith DJ; Allen DM; Baker D; Bloch M; Bopage RI; Brown K; Carr A; Carmody CJ; Collins KL; Finlayson R; Foster R; Jackson EY; Lewis DA; Lusk J; O'Connor CC; Ryder N; Vlahakis E; Read P; Cooper DA;
    Lancet HIV; 2018 Nov; 5(11):e629-e637. PubMed ID: 30343026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socio-behavioral correlates of pre-exposure prophylaxis use and correct adherence in men who have sex with men in West Africa.
    Eubanks A; Coulibaly B; Dembélé Keita B; Anoma C; Dah TTE; Mensah E; Kaba S; Lokrou KJ; Ouedraogo FR; Badjassim AMF; Maradan G; Bourrelly M; Mora M; Riegel L; Rojas Castro D; Yaya I; Spire B; Laurent C; Sagaon-Teyssier L;
    BMC Public Health; 2022 Sep; 22(1):1832. PubMed ID: 36175860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitators and barriers of 2-1-1 HIV pre-exposure prophylaxis.
    Camp C; Saberi P
    PLoS One; 2021; 16(5):e0251917. PubMed ID: 34014998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Condomless Anal Sex Associated With Heterogeneous Profiles Of HIV Pre-Exposure Prophylaxis Use and Sexual Activities Among Men Who Have Sex With Men: A Latent Class Analysis Using Sex Diary Data on a Mobile App.
    Yu YF; Wu HJ; Ku SW; Huang PH; Li CW; Huang P; Strong C
    J Med Internet Res; 2021 Dec; 23(12):e33877. PubMed ID: 34941560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroconversion rate of SARS-CoV-2 IgG antibodies and dating behaviour in HIV-PrEP users in a German metropolis during the COVID-19 pandemic.
    Weidlich S; Schneider J; Lee M; Mijočević H; Graf N; Protzer U; Spinner C; Noe S
    Int J STD AIDS; 2023 Nov; 34(13):956-961. PubMed ID: 37461288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between daily and on-demand PrEP (pre-exposure prophylaxis) regimen in covering condomless anal intercourse for men who have sex with men in Hong Kong: A randomized, controlled, open-label, crossover trial.
    Kwan TH; Lui GCY; Lam TTN; Lee KCK; Wong NS; Chan DPC; Lee SS
    J Int AIDS Soc; 2021 Sep; 24(9):e25795. PubMed ID: 34473402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: Results from a prospective observational study in Germany.
    Uhrmacher M; Skaletz-Rorowski A; Nambiar S; Schmidt AJ; Ahaus P; Serova K; Mordhorst I; Kayser A; Wach J; Tiemann C; Münstermann D; Brockmeyer NH; Potthoff A
    Front Public Health; 2022; 10():930208. PubMed ID: 36091531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol-antiretroviral interactive toxicity beliefs as a potential barrier to HIV pre-exposure prophylaxis among men who have sex with men.
    Kalichman SC; Eaton L
    J Int AIDS Soc; 2017 Jul; 20(1):21534. PubMed ID: 28715159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.